Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical OutcomeRichard W. Tothill, David D.L. Bowtell, Daryl Johnson et al.|Clinical Cancer Research|2008Cited by 1.5k
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian CarcinomasDariush Etemadmoghadam, David D.L. Bowtell, Anna DeFazio et al.|Clinical Cancer Research|2009Cited by 310
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential TumorsMichael S. Anglesio, David D.L. Bowtell, Jeremy M. Arnold et al.|Molecular Cancer Research|2008Cited by 130